Matt Hewitt

Stock Analyst at Craig-Hallum

(2.69)
# 1,979
Out of 4,886 analysts
40
Total ratings
51.35%
Success rate
4.12%
Average return

Stocks Rated by Matt Hewitt

Simulations Plus
Jun 13, 2025
Maintains: Buy
Price Target: $45$36
Current: $16.83
Upside: +113.90%
Champions Oncology
Mar 12, 2025
Maintains: Buy
Price Target: $8$12
Current: $8.50
Upside: +41.18%
Clover Health Investments
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $2.89
Upside: +107.61%
BioLife Solutions
Nov 13, 2024
Maintains: Buy
Price Target: $30$32
Current: $21.83
Upside: +46.59%
Omnicell
Oct 31, 2024
Maintains: Buy
Price Target: $45$64
Current: $28.92
Upside: +121.30%
Inotiv
May 16, 2024
Maintains: Buy
Price Target: $25$10
Current: $2.05
Upside: +387.80%
Schrödinger
May 2, 2024
Maintains: Buy
Price Target: $35$30
Current: $20.63
Upside: +45.42%
MaxCyte
Nov 29, 2023
Initiates: Buy
Price Target: $7
Current: $2.17
Upside: +222.58%
Repligen
Aug 3, 2023
Maintains: Buy
Price Target: $207$200
Current: $124.43
Upside: +60.73%
OmniAb
Apr 13, 2023
Initiates: Buy
Price Target: $10
Current: $1.87
Upside: +434.76%
Maintains: Hold
Price Target: $67$30
Current: $8.07
Upside: +271.75%
Initiates: Buy
Price Target: $400
Current: $0.96
Upside: +41,566.67%